ATE543804T1 - Neue verbindungen - Google Patents
Neue verbindungenInfo
- Publication number
- ATE543804T1 ATE543804T1 AT07821145T AT07821145T ATE543804T1 AT E543804 T1 ATE543804 T1 AT E543804T1 AT 07821145 T AT07821145 T AT 07821145T AT 07821145 T AT07821145 T AT 07821145T AT E543804 T1 ATE543804 T1 AT E543804T1
- Authority
- AT
- Austria
- Prior art keywords
- new connections
- compounds
- preparation
- treatment
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0620385.5A GB0620385D0 (en) | 2006-10-13 | 2006-10-13 | Novel compounds |
| PCT/EP2007/060777 WO2008043789A1 (en) | 2006-10-13 | 2007-10-10 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE543804T1 true ATE543804T1 (de) | 2012-02-15 |
Family
ID=37491500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07821145T ATE543804T1 (de) | 2006-10-13 | 2007-10-10 | Neue verbindungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7947727B2 (de) |
| EP (1) | EP2081910B1 (de) |
| JP (1) | JP2010505911A (de) |
| AT (1) | ATE543804T1 (de) |
| ES (1) | ES2380830T3 (de) |
| GB (1) | GB0620385D0 (de) |
| PL (1) | PL2081910T3 (de) |
| WO (1) | WO2008043789A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200829578A (en) | 2006-11-23 | 2008-07-16 | Astrazeneca Ab | Chemical compounds 537 |
| JO2754B1 (en) | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| GB0720556D0 (en) * | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| GB0720557D0 (en) * | 2007-10-19 | 2007-11-28 | Glaxo Group Ltd | Novel compounds |
| WO2009069736A1 (ja) * | 2007-11-28 | 2009-06-04 | Kyowa Hakko Kirin Co., Ltd. | 含窒素化合物 |
| TWI445705B (zh) | 2008-05-20 | 2014-07-21 | Astrazeneca Ab | 經苯基及苯并二基取代之吲唑衍生物 |
| EP2459182B1 (de) | 2009-07-30 | 2017-09-06 | University of Zürich | Injizierbare formulierung für behandlung und schutz von patienten mit einer entzündungsreaktion oder einem ischämie-reperfusionsereignis |
| TW201927769A (zh) | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | 經取代之吡咯啶醯胺ｉｉ |
| MX2020006348A (es) | 2017-12-18 | 2020-09-03 | Gruenenthal Gmbh | Pirrolidinamidas i sustituidas. |
| CN113382990A (zh) | 2019-01-11 | 2021-09-10 | 格吕伦塔尔有限公司 | 取代的吡咯烷酰胺iii |
| WO2020254551A1 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides iv |
| EP3986886A2 (de) | 2019-06-19 | 2022-04-27 | Grünenthal GmbH | Substituierte pyrrolidinamide v |
| EP4178954A1 (de) | 2020-07-09 | 2023-05-17 | Grünenthal GmbH | Substituierte pyrrolidinamine und amide als vermittler des glucocortoidrezeptors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003202216A1 (en) | 2002-01-14 | 2003-07-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| BRPI0412231A (pt) * | 2003-07-01 | 2006-08-22 | Schering Ag | derivados de pentanol substituìdos heterociclicamente, processos para a sua preparação e sua aplicação como inibidores de inflamação |
| UY28526A1 (es) * | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
| JP2008535884A (ja) * | 2005-04-14 | 2008-09-04 | グラクソ グループ リミテッド | グルココルチコイド受容体リガンドとしてのインダゾール |
| TW200815361A (en) | 2005-10-20 | 2008-04-01 | Astrazeneca Ab | Chemical compounds |
-
2006
- 2006-10-13 GB GBGB0620385.5A patent/GB0620385D0/en not_active Ceased
-
2007
- 2007-10-10 PL PL07821145T patent/PL2081910T3/pl unknown
- 2007-10-10 JP JP2009531838A patent/JP2010505911A/ja active Pending
- 2007-10-10 US US12/444,713 patent/US7947727B2/en active Active
- 2007-10-10 AT AT07821145T patent/ATE543804T1/de active
- 2007-10-10 ES ES07821145T patent/ES2380830T3/es active Active
- 2007-10-10 EP EP07821145A patent/EP2081910B1/de active Active
- 2007-10-10 WO PCT/EP2007/060777 patent/WO2008043789A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| PL2081910T3 (pl) | 2012-07-31 |
| WO2008043789A1 (en) | 2008-04-17 |
| EP2081910B1 (de) | 2012-02-01 |
| EP2081910A1 (de) | 2009-07-29 |
| ES2380830T3 (es) | 2012-05-18 |
| GB0620385D0 (en) | 2006-11-22 |
| JP2010505911A (ja) | 2010-02-25 |
| US20100120883A1 (en) | 2010-05-13 |
| US7947727B2 (en) | 2011-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE543804T1 (de) | Neue verbindungen | |
| NO20085100L (no) | Nye forbindelser | |
| MA32200B1 (fr) | Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation | |
| LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
| EA200801997A1 (ru) | Новые соединения | |
| EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
| EA201200551A1 (ru) | Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения | |
| MY140826A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments. | |
| ATE524450T1 (de) | 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren | |
| EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
| TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| EA201270492A1 (ru) | Соединения для лечения дислипидемии и связанных с ней заболеваний | |
| TW200738699A (en) | 4-Substituted pyrazoline compounds, their preparation and use as medicaments | |
| EA201100623A1 (ru) | Сульфоксиминзамещенные анилинопиримидиновые производные в качестве cdk ингибиторов, их получение и применение в качестве лекарственных средств | |
| WO2008043788A3 (en) | Novel compounds | |
| MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
| EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
| CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
| BRPI0606140A2 (pt) | tiazolidinonas, preparação e uso das mesmas como medicamento | |
| TW200745042A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MX2008011020A (es) | Compuestos de receptor sigma. | |
| ATE371724T1 (de) | Behandlung neurodegenerativer krankheiten | |
| DK1786442T3 (da) | Behandling af neurodegenerative sygdomme under anvendelse af DEGS-inhibitorer |